296 related articles for article (PubMed ID: 22560714)
1. Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans.
Stuschke M; Kaiser A; Pöttgen C; Lübcke W; Farr J
Radiother Oncol; 2012 Jul; 104(1):45-51. PubMed ID: 22560714
[TBL] [Abstract][Full Text] [Related]
2. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
3. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
4. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
[TBL] [Abstract][Full Text] [Related]
5. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
[TBL] [Abstract][Full Text] [Related]
6. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
[TBL] [Abstract][Full Text] [Related]
7. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
[TBL] [Abstract][Full Text] [Related]
8. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
Baumert BG; Norton IA; Lomax AJ; Davis JB
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
[TBL] [Abstract][Full Text] [Related]
9. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
Seco J; Gu G; Marcelos T; Kooy H; Willers H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
[TBL] [Abstract][Full Text] [Related]
10. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.
Munck Af Rosenschöld P; Engelholm S; Ohlhues L; Law I; Vogelius I; Engelholm SA
Acta Oncol; 2011 Aug; 50(6):777-83. PubMed ID: 21767174
[TBL] [Abstract][Full Text] [Related]
11. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours.
Petersen JB; Lassen Y; Hansen AT; Muren LP; Grau C; Høyer M
Acta Oncol; 2011 Aug; 50(6):823-8. PubMed ID: 21767180
[TBL] [Abstract][Full Text] [Related]
12. Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy.
Li X; Kabolizadeh P; Yan D; Qin A; Zhou J; Hong Y; Guerrero T; Grills I; Stevens C; Ding X
Radiat Oncol; 2018 Feb; 13(1):35. PubMed ID: 29486782
[TBL] [Abstract][Full Text] [Related]
13. Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study.
Marnitz S; Stuschke M; Bohsung J; Moys A; Reng I; Wurm R; Budach V
Strahlenther Onkol; 2002 Nov; 178(11):651-8. PubMed ID: 12426677
[TBL] [Abstract][Full Text] [Related]
14. Dose painting with IMPT, helical tomotherapy and IMXT: a dosimetric comparison.
Thorwarth D; Soukup M; Alber M
Radiother Oncol; 2008 Jan; 86(1):30-4. PubMed ID: 18061294
[TBL] [Abstract][Full Text] [Related]
15. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
[TBL] [Abstract][Full Text] [Related]
16. Is it necessary to plan with safety margins for actively scanned proton therapy?
Albertini F; Hug EB; Lomax AJ
Phys Med Biol; 2011 Jul; 56(14):4399-413. PubMed ID: 21709340
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
Milby AB; Both S; Ingram M; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Pencil Beam Scanned Intensity Modulated Proton Therapy in Breath-hold for Locally Advanced Non-Small Cell Lung Cancer.
Gorgisyan J; Munck Af Rosenschold P; Perrin R; Persson GF; Josipovic M; Belosi MF; Engelholm SA; Weber DC; Lomax AJ
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1121-1128. PubMed ID: 28964587
[TBL] [Abstract][Full Text] [Related]
20. Robust treatment planning with 4D intensity modulated carbon ion therapy for multiple targets in stage IV non-small cell lung cancer.
Wolf M; Anderle K; Durante M; Graeff C
Phys Med Biol; 2020 Nov; 65(21):215012. PubMed ID: 32610300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
